Background illustration for clinical trials search

Paid Clinical Trials Joliet

Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,355

A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

for

IBS (Irritable Bowel Syndrome)

Location: Bolingbrook IL, Southhaven MS, Kissimmee FL

Sponsor: PGP Health

Sex: All

Age: 18 - 60

Code: NCT07540312

Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for

Pancreatic Neoplasm

Location: Plainfield IL, Orland Park IL, Naperville IL,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for

Breast Cancer, Depression

Location: Plainfield IL, Orland Park IL, Naperville IL, Lisle IL,

Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for

Prostate Cancer (Adenocarcinoma)

Location: Plainfield IL, Naperville IL, Elmhurst IL, Chicago IL,

Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Location: Plainfield IL, Orland Park IL, Naperville IL, Aurora IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Plainfield IL, Orland Park IL, Naperville IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

for

Acute Gout Flare, Gout Attack, Gout Flare, Gouty Arthritis,

Location: Orland Park IL, Gainesville GA, Summerville SC,

Sponsor: Olatec Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05658575

Phase2, Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for

Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,

Location: Orland Park IL, Elgin IL, O'Fallon MO, Memphis TN,

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07172516

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

for

Major Depressive Disorder

Location: Orland Park IL, Saint Charles MO, O'Fallon MO,

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07076407

Phase3, Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for

Neovascular Age-Related Macular Degeneration (NVAMD),

Location: Lemont IL, Nashville TN, Charleston WV, Knoxville TN,

Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

New

Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection

for

Osteoarthitis, Osteoarthritic Knee Pain, Osteoarthritis (OA),

Location: Bolingbrook IL, Orland Park IL, Woodridge IL,

Sponsor: University of Chicago

Sex: All

Age: 40+

Code: NCT07804446

Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Tinley Park IL, Winfield IL, Melrose Park IL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Clarifying the Optimal Application of SLT Therapy Trial

for

Glaucoma and Ocular Hypertension

Location: Orland Park IL, Chicago IL, Peoria IL, Madison WI,

Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT04967989

Phase3, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for

Endometrial Cancer

Location: Orland Park IL, Warrenville IL, Chicago IL,

Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase2, Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

for

Metastatic Bladder Urothelial Carcinoma,

Location: Orland Park IL, Chicago IL

Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06630416

Phase2, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,

Location: Orland Park IL, Warrenville IL, Oak Brook IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

for

Hepatocellular Carcinoma

Location: Orland Park IL, Warrenville IL, Geneva IL, Chicago IL,

Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05620771

Phase2, Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for

Anatomic Stage II Breast Cancer AJCC v8,

Location: Orland Park IL, Warrenville IL, Oak Brook IL, Geneva IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07391774

Phase3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Orland Park IL, Oak Park IL, Chicago IL, Ottawa IL,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase3, Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Location: Orland Park IL, Lisle IL, Warrenville IL, Oak Brook IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase2, Recruiting

Paid Clinical Trials Joliet

Filter results

A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

E-Mindfulness Approaches for Living After Breast Cancer

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Interested in new trials?

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Clarifying the Optimal Application of SLT Therapy Trial

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer